Specgx
As of the edition of 20 October 2026, Specgx runs 9 drugs, 9 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 9 |
| Total | 9 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Morphine | none listed | 2 |
| Methylphenidate | none listed | 11 |
| Oxycodone | none listed | 2 |
| Methadone | none listed | 2 |
| Hydromorphone | none listed | 1 |
| Imipramine | none listed | 1 |
| Nortriptyline | none listed | 1 |
| Clomipramine | none listed | 0 |
| Temazepam | none listed | 0 |
A route B row is one company at one target.